Sotera Health Company $SHC Shares Acquired by Envestnet Portfolio Solutions Inc.

Key Points

• Envestnet Portfolio Solutions Inc. significantly increased its stake in Sotera Health Company by 312.8% in Q2, owning 65,975 shares valued at approximately $734,000.
• Several brokers have mixed ratings on Sotera Health, with Wall Street Zen upgrading the stock to a "strong-buy," while Barclays raised its price target from $17.00 to $19.00.
• Insider activity showed significant share sales, with a director selling 12 million shares for around $181.3 million, indicating a 16.26% decrease in their position.

Envestnet Portfolio Solutions Inc. increased its stake in Sotera Health Company (NASDAQ:SHC - Free Report) by 312.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,975 shares of the company's stock after purchasing an additional 49,992 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Sotera Health were worth $734,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. raised its position in Sotera Health by 112.8% in the second quarter. UMB Bank n.a. now owns 2,635 shares of the company's stock worth $29,000 after acquiring an additional 1,397 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock worth $31,000 after acquiring an additional 2,620 shares in the last quarter. Parallel Advisors LLC raised its position in Sotera Health by 124.0% in the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company's stock worth $37,000 after acquiring an additional 1,849 shares in the last quarter. Summit Securities Group LLC bought a new stake in Sotera Health in the first quarter worth about $67,000. Finally, Farther Finance Advisors LLC raised its position in Sotera Health by 4,881.9% in the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after acquiring an additional 6,200 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on SHC. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 16th. Weiss Ratings reiterated a "sell (d)" rating on shares of Sotera Health in a research report on Wednesday, October 8th. Finally, Barclays upped their price objective on shares of Sotera Health from $17.00 to $19.00 and gave the company an "overweight" rating in a research note on Thursday, October 2nd. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Sotera Health presently has an average rating of "Moderate Buy" and an average price target of $17.20.

Insider Activity

In other news, Director Pincus & Co. Warburg sold 12,000,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $181,320,000.00. Following the transaction, the director owned 61,822,952 shares in the company, valued at $934,144,804.72. This represents a 16.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the company's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the completion of the transaction, the director owned 41,215,301 shares in the company, valued at $622,763,198.11. This represents a 16.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,126,611 shares of company stock worth $304,273,888 in the last 90 days. Company insiders own 55.12% of the company's stock.

Sotera Health Trading Up 3.4%

NASDAQ SHC opened at $16.71 on Tuesday. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.04. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. The stock has a market cap of $4.75 billion, a price-to-earnings ratio of 208.90 and a beta of 1.82. The firm's 50 day moving average price is $15.99 and its two-hundred day moving average price is $13.21.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to analysts' expectations of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Equities analysts anticipate that Sotera Health Company will post 0.61 EPS for the current year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.